Skip to main content

Table 1 Population characteristics of the cohorts of children hospitalized in the Pediatric Department due to bronchiolitis

From: The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy

 

2017–2018 N = 29

2018–2019 N = 25

2019–2020 N = 35

2020–2021 N = 2

2021–2022 N = 50

Total N = 141

Age (days), median (min–max)

72 (25–338)

73 (37–358)

78 (22–247)

31 (27–34)

63 (22–316)

40 (22–358)

Risk factors (none/other disease/prematurity)

8/29 (21/2/6)

5/25 (20/2/3)

11/35 (24/4/7)

0/2 (2/0/0)

13/50 (37/6/7)

37/141 (104/14/23)

Silverman Score (0/1/2/3/unknown)

3/11/10/3/2

9/8/7/1/0

5/13/16/1/0

1/1/0/0/0

8/13/24/5/0

26/46/57/10/2

O2 Saturation, median (min–max)

93 (86–100)

92 (77–100)

95 (88–100)

98 (97–100)

95 (78–100)

89 (77–100)

Weight (kg), median (min–max)

5 (3.5–9)

5.5 (4–9.7)

5.25 (3.16–9.05)

4.75 (4–10.2)

4.9 (2.8–9.3)

4.2 (2.8–10.2)

Length of Admission (days), median (min–max)

7 (2–43)

7 (3–13)

6 (2–17)

3 (3–4)

7 (2–20)

6.5 (2–43)

Respiratory Support (none/O2 low flow/HFNC/CPAP)

27/29 (2/4/22/1)

19/25 (6/3/12/4)

28/35 (7/4/23/1)

1/2 (1/0/1/0)

42/50 (8/5/33/4)

116/141 (24/16/91/10)

Length of Respiratory Support, days, median (min–max)

5.5 (0–21)

6 (0–12)

4 (0–13)

0.5 (0–1)

6 (0–19)

5.5 (0–21)

Need of Intensive Care Unit, (%)

7/29 (24%)

4/25 (16%)

5/35 (14%)

0/2 (0%)

20/50 (40%)

36/141 (25%)

Need for nasogastric feeding

5/29

3/25

4/35

0/2

10/50

22/141

Need for intravenous fluids

12/29

17/25

13/35

0/2

15/50

57/141

Viral etiology (RSV/ non RSV/ unknown)

23/4/2

18/6/1

23/8/4

0/2/0

39/11/0

103/31/7

  1. HFNC High Flow Nasal Cannulae, CPAP continuous positive airway pressure, RSV Respiratory Syncytial Virus